Literature Recap: February 16-28, 2023
Posted in Papers / Original Research / Human Studies / Editor's Picks / February 16-28, 2023
Sex Hormones and Calcitonin Gene-Related Peptide in Women With Migraine: A Cross-sectional, Matched Cohort Study
Posted in Papers / Original Research / Human Studies / Editor's Picks / February 16-28, 2023
Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial
Posted in Papers / Reviews / Editor's Picks / February 16-28, 2023
Genetics of migraine: where are we now?
Posted in Papers / Reviews / Editor's Picks / February 16-28, 2023
The sense of stopping migraine prophylaxis
Posted in Papers / Original Research / Editor's Picks / Animal Studies / February 16-28, 2023
Neuronal NLRP3 inflammasome mediates spreading depolarization-evoked trigeminovascular activation
Posted in Papers / Original Research / Human Studies / February 16-28, 2023
A study of differential microRNA expression profile in migraine: the microMIG exploratory study
Posted in Papers / Original Research / Human Studies / February 16-28, 2023
Clinical evaluation of super-responders vs. non-responders to CGRP(-receptor) monoclonal antibodies: a real-world experience
Posted in Papers / Original Research / Human Studies / February 16-28, 2023
One-Time Use of Galcanezumab or Fremanezumab for Migraine Prevention
Posted in Papers / Reviews / February 16-28, 2023
Review of Tolerability of Fremanezumab for Episodic and Chronic Migraine
Posted in Papers / Original Research / Human Studies / February 16-28, 2023